Preclinical evidence suggests that hyperuricemia may exacerbate RA autoimmune pathogenesis through dual mechanisms: crystal-dependent NLRP3 inflammasome activation and crystal-independent enhancement of Th17 differentiation (14). This evidence concerns the gene NLRP3 and rheumatoid arthritis.